nodes	percent_of_prediction	percent_of_DWPC	metapath
Efavirenz—CYP1A2—Anagrelide—hematologic cancer	0.0336	0.0491	CbGbCtD
Efavirenz—CYP2B6—Thiotepa—hematologic cancer	0.0329	0.0481	CbGbCtD
Efavirenz—CYP2C9—Bexarotene—hematologic cancer	0.021	0.0306	CbGbCtD
Efavirenz—CYP2B6—Ifosfamide—hematologic cancer	0.0187	0.0273	CbGbCtD
Efavirenz—CYP2D6—Lomustine—hematologic cancer	0.0179	0.0261	CbGbCtD
Efavirenz—CYP1A2—Carmustine—hematologic cancer	0.0177	0.0258	CbGbCtD
Efavirenz—CYP2C9—Idarubicin—hematologic cancer	0.0174	0.0254	CbGbCtD
Efavirenz—CYP2B6—Nilotinib—hematologic cancer	0.0162	0.0237	CbGbCtD
Efavirenz—CYP2D6—Idarubicin—hematologic cancer	0.0159	0.0232	CbGbCtD
Efavirenz—CYP2C19—Bortezomib—hematologic cancer	0.0155	0.0226	CbGbCtD
Efavirenz—CYP1A2—Methoxsalen—hematologic cancer	0.015	0.0219	CbGbCtD
Efavirenz—CYP1A2—Bortezomib—hematologic cancer	0.0143	0.0208	CbGbCtD
Efavirenz—CYP1A2—Daunorubicin—hematologic cancer	0.0137	0.0199	CbGbCtD
Efavirenz—CYP2D6—Hydroxyurea—hematologic cancer	0.0135	0.0197	CbGbCtD
Efavirenz—CYP2C19—Thalidomide—hematologic cancer	0.0135	0.0197	CbGbCtD
Efavirenz—CYP1A2—Alitretinoin—hematologic cancer	0.0134	0.0195	CbGbCtD
Efavirenz—CYP2C9—Bortezomib—hematologic cancer	0.0129	0.0188	CbGbCtD
Efavirenz—CYP2C19—Teniposide—hematologic cancer	0.0129	0.0188	CbGbCtD
Efavirenz—CYP1A2—Thalidomide—hematologic cancer	0.0124	0.0182	CbGbCtD
Efavirenz—CYP3A4—Bexarotene—hematologic cancer	0.0122	0.0178	CbGbCtD
Efavirenz—CYP2C19—Ifosfamide—hematologic cancer	0.0119	0.0173	CbGbCtD
Efavirenz—CYP2D6—Bortezomib—hematologic cancer	0.0118	0.0172	CbGbCtD
Efavirenz—CYP3A4—Busulfan—hematologic cancer	0.0114	0.0166	CbGbCtD
Efavirenz—CYP3A4—Lomustine—hematologic cancer	0.0114	0.0166	CbGbCtD
Efavirenz—CYP2C19—Imatinib—hematologic cancer	0.0113	0.0166	CbGbCtD
Efavirenz—CYP2C9—Thalidomide—hematologic cancer	0.0112	0.0164	CbGbCtD
Efavirenz—CYP2B6—Irinotecan—hematologic cancer	0.0112	0.0163	CbGbCtD
Efavirenz—CYP1A2—Dacarbazine—hematologic cancer	0.0107	0.0156	CbGbCtD
Efavirenz—CYP2C9—Teniposide—hematologic cancer	0.0107	0.0156	CbGbCtD
Efavirenz—CYP1A2—Imatinib—hematologic cancer	0.0105	0.0153	CbGbCtD
Efavirenz—CYP3A4—Thiotepa—hematologic cancer	0.0101	0.0148	CbGbCtD
Efavirenz—CYP2C9—Ifosfamide—hematologic cancer	0.00987	0.0144	CbGbCtD
Efavirenz—CYP2C9—Imatinib—hematologic cancer	0.00943	0.0138	CbGbCtD
Efavirenz—CYP2B6—Cisplatin—hematologic cancer	0.00909	0.0133	CbGbCtD
Efavirenz—CYP2D6—Imatinib—hematologic cancer	0.00863	0.0126	CbGbCtD
Efavirenz—CYP2C9—Nilotinib—hematologic cancer	0.00857	0.0125	CbGbCtD
Efavirenz—CYP1A2—Dasatinib—hematologic cancer	0.00841	0.0123	CbGbCtD
Efavirenz—CYP3A4—Methoxsalen—hematologic cancer	0.00787	0.0115	CbGbCtD
Efavirenz—CYP2D6—Nilotinib—hematologic cancer	0.00784	0.0114	CbGbCtD
Efavirenz—CYP2D6—Vinorelbine—hematologic cancer	0.00777	0.0113	CbGbCtD
Efavirenz—CYP3A4—Bortezomib—hematologic cancer	0.00749	0.0109	CbGbCtD
Efavirenz—CYP2C19—Prednisone—hematologic cancer	0.00748	0.0109	CbGbCtD
Efavirenz—CYP2B6—Dexamethasone—hematologic cancer	0.00734	0.0107	CbGbCtD
Efavirenz—CYP3A4—Daunorubicin—hematologic cancer	0.00716	0.0104	CbGbCtD
Efavirenz—CYP3A4—Cytarabine—hematologic cancer	0.00632	0.00921	CbGbCtD
Efavirenz—CYP3A4—Teniposide—hematologic cancer	0.00622	0.00908	CbGbCtD
Efavirenz—CYP2B6—Doxorubicin—hematologic cancer	0.00609	0.00889	CbGbCtD
Efavirenz—CYP3A4—Ifosfamide—hematologic cancer	0.00574	0.00838	CbGbCtD
Efavirenz—CYP3A4—Imatinib—hematologic cancer	0.00548	0.008	CbGbCtD
Efavirenz—CYP1A2—Etoposide—hematologic cancer	0.00524	0.00764	CbGbCtD
Efavirenz—CYP3A4—Ruxolitinib—hematologic cancer	0.00516	0.00753	CbGbCtD
Efavirenz—CYP3A4—Nilotinib—hematologic cancer	0.00498	0.00727	CbGbCtD
Efavirenz—CYP3A4—Vinorelbine—hematologic cancer	0.00494	0.00721	CbGbCtD
Efavirenz—CYP2C9—Cisplatin—hematologic cancer	0.0048	0.00701	CbGbCtD
Efavirenz—CYP2D6—Vinblastine—hematologic cancer	0.00479	0.00699	CbGbCtD
Efavirenz—CYP2C19—Dexamethasone—hematologic cancer	0.00467	0.00681	CbGbCtD
Efavirenz—CYP3A4—Triamcinolone—hematologic cancer	0.00452	0.00659	CbGbCtD
Efavirenz—CYP3A4—Dasatinib—hematologic cancer	0.00441	0.00643	CbGbCtD
Efavirenz—CYP3A4—Mitoxantrone—hematologic cancer	0.00435	0.00635	CbGbCtD
Efavirenz—CYP2C9—Dexamethasone—hematologic cancer	0.00388	0.00566	CbGbCtD
Efavirenz—CYP3A4—Betamethasone—hematologic cancer	0.00388	0.00566	CbGbCtD
Efavirenz—CYP3A4—Prednisolone—hematologic cancer	0.00383	0.00558	CbGbCtD
Efavirenz—CYP3A4—Prednisone—hematologic cancer	0.00361	0.00527	CbGbCtD
Efavirenz—CYP2D6—Dexamethasone—hematologic cancer	0.00355	0.00518	CbGbCtD
Efavirenz—CYP3A4—Irinotecan—hematologic cancer	0.00343	0.005	CbGbCtD
Efavirenz—CYP3A4—Vinblastine—hematologic cancer	0.00305	0.00444	CbGbCtD
Efavirenz—CYP3A4—Vincristine—hematologic cancer	0.00299	0.00437	CbGbCtD
Efavirenz—CYP2D6—Doxorubicin—hematologic cancer	0.00294	0.00429	CbGbCtD
Efavirenz—CYP3A4—Etoposide—hematologic cancer	0.00274	0.004	CbGbCtD
Efavirenz—CYP3A4—Dexamethasone—hematologic cancer	0.00226	0.00329	CbGbCtD
Efavirenz—CYP3A4—Doxorubicin—hematologic cancer	0.00187	0.00273	CbGbCtD
Efavirenz—Vomiting—Cisplatin—hematologic cancer	2.11e-05	7.16e-05	CcSEcCtD
Efavirenz—Hyperhidrosis—Prednisone—hematologic cancer	2.11e-05	7.15e-05	CcSEcCtD
Efavirenz—Vision blurred—Methotrexate—hematologic cancer	2.11e-05	7.14e-05	CcSEcCtD
Efavirenz—Erythema multiforme—Doxorubicin—hematologic cancer	2.1e-05	7.12e-05	CcSEcCtD
Efavirenz—Rash—Cisplatin—hematologic cancer	2.1e-05	7.1e-05	CcSEcCtD
Efavirenz—Dermatitis—Cisplatin—hematologic cancer	2.09e-05	7.09e-05	CcSEcCtD
Efavirenz—Malnutrition—Epirubicin—hematologic cancer	2.09e-05	7.09e-05	CcSEcCtD
Efavirenz—Erythema—Epirubicin—hematologic cancer	2.09e-05	7.09e-05	CcSEcCtD
Efavirenz—Diarrhoea—Etoposide—hematologic cancer	2.08e-05	7.06e-05	CcSEcCtD
Efavirenz—Anorexia—Prednisone—hematologic cancer	2.08e-05	7.05e-05	CcSEcCtD
Efavirenz—Eye disorder—Doxorubicin—hematologic cancer	2.08e-05	7.04e-05	CcSEcCtD
Efavirenz—Ill-defined disorder—Methotrexate—hematologic cancer	2.07e-05	7.03e-05	CcSEcCtD
Efavirenz—Tinnitus—Doxorubicin—hematologic cancer	2.07e-05	7.02e-05	CcSEcCtD
Efavirenz—Anaemia—Methotrexate—hematologic cancer	2.07e-05	7e-05	CcSEcCtD
Efavirenz—Feeling abnormal—Dexamethasone—hematologic cancer	2.06e-05	7e-05	CcSEcCtD
Efavirenz—Feeling abnormal—Betamethasone—hematologic cancer	2.06e-05	7e-05	CcSEcCtD
Efavirenz—Flushing—Doxorubicin—hematologic cancer	2.06e-05	6.99e-05	CcSEcCtD
Efavirenz—Cardiac disorder—Doxorubicin—hematologic cancer	2.06e-05	6.99e-05	CcSEcCtD
Efavirenz—Flatulence—Epirubicin—hematologic cancer	2.06e-05	6.98e-05	CcSEcCtD
Efavirenz—Tension—Epirubicin—hematologic cancer	2.05e-05	6.95e-05	CcSEcCtD
Efavirenz—Gastrointestinal pain—Betamethasone—hematologic cancer	2.05e-05	6.94e-05	CcSEcCtD
Efavirenz—Gastrointestinal pain—Dexamethasone—hematologic cancer	2.05e-05	6.94e-05	CcSEcCtD
Efavirenz—Dysgeusia—Epirubicin—hematologic cancer	2.05e-05	6.94e-05	CcSEcCtD
Efavirenz—Hypersensitivity—Triamcinolone—hematologic cancer	2.03e-05	6.9e-05	CcSEcCtD
Efavirenz—Nervousness—Epirubicin—hematologic cancer	2.03e-05	6.88e-05	CcSEcCtD
Efavirenz—Back pain—Epirubicin—hematologic cancer	2.02e-05	6.86e-05	CcSEcCtD
Efavirenz—Angiopathy—Doxorubicin—hematologic cancer	2.02e-05	6.83e-05	CcSEcCtD
Efavirenz—Malaise—Methotrexate—hematologic cancer	2.02e-05	6.83e-05	CcSEcCtD
Efavirenz—Dizziness—Etoposide—hematologic cancer	2.01e-05	6.82e-05	CcSEcCtD
Efavirenz—Immune system disorder—Doxorubicin—hematologic cancer	2.01e-05	6.8e-05	CcSEcCtD
Efavirenz—Vertigo—Methotrexate—hematologic cancer	2.01e-05	6.8e-05	CcSEcCtD
Efavirenz—Mediastinal disorder—Doxorubicin—hematologic cancer	2e-05	6.79e-05	CcSEcCtD
Efavirenz—Urticaria—Betamethasone—hematologic cancer	1.99e-05	6.75e-05	CcSEcCtD
Efavirenz—Urticaria—Dexamethasone—hematologic cancer	1.99e-05	6.75e-05	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Prednisone—hematologic cancer	1.99e-05	6.74e-05	CcSEcCtD
Efavirenz—Dizziness—Prednisolone—hematologic cancer	1.99e-05	6.73e-05	CcSEcCtD
Efavirenz—Arrhythmia—Doxorubicin—hematologic cancer	1.99e-05	6.73e-05	CcSEcCtD
Efavirenz—Asthenia—Triamcinolone—hematologic cancer	1.98e-05	6.71e-05	CcSEcCtD
Efavirenz—Abdominal pain—Betamethasone—hematologic cancer	1.98e-05	6.71e-05	CcSEcCtD
Efavirenz—Body temperature increased—Betamethasone—hematologic cancer	1.98e-05	6.71e-05	CcSEcCtD
Efavirenz—Abdominal pain—Dexamethasone—hematologic cancer	1.98e-05	6.71e-05	CcSEcCtD
Efavirenz—Body temperature increased—Dexamethasone—hematologic cancer	1.98e-05	6.71e-05	CcSEcCtD
Efavirenz—Nausea—Cisplatin—hematologic cancer	1.97e-05	6.69e-05	CcSEcCtD
Efavirenz—Insomnia—Prednisone—hematologic cancer	1.97e-05	6.69e-05	CcSEcCtD
Efavirenz—Vision blurred—Epirubicin—hematologic cancer	1.97e-05	6.68e-05	CcSEcCtD
Efavirenz—Alopecia—Doxorubicin—hematologic cancer	1.96e-05	6.66e-05	CcSEcCtD
Efavirenz—Paraesthesia—Prednisone—hematologic cancer	1.96e-05	6.64e-05	CcSEcCtD
Efavirenz—Pruritus—Triamcinolone—hematologic cancer	1.95e-05	6.62e-05	CcSEcCtD
Efavirenz—Cough—Methotrexate—hematologic cancer	1.95e-05	6.61e-05	CcSEcCtD
Efavirenz—Ill-defined disorder—Epirubicin—hematologic cancer	1.94e-05	6.58e-05	CcSEcCtD
Efavirenz—Convulsion—Methotrexate—hematologic cancer	1.94e-05	6.56e-05	CcSEcCtD
Efavirenz—Vomiting—Etoposide—hematologic cancer	1.94e-05	6.56e-05	CcSEcCtD
Efavirenz—Malnutrition—Doxorubicin—hematologic cancer	1.93e-05	6.56e-05	CcSEcCtD
Efavirenz—Erythema—Doxorubicin—hematologic cancer	1.93e-05	6.56e-05	CcSEcCtD
Efavirenz—Anaemia—Epirubicin—hematologic cancer	1.93e-05	6.55e-05	CcSEcCtD
Efavirenz—Agitation—Epirubicin—hematologic cancer	1.92e-05	6.51e-05	CcSEcCtD
Efavirenz—Dyspepsia—Prednisone—hematologic cancer	1.92e-05	6.51e-05	CcSEcCtD
Efavirenz—Rash—Etoposide—hematologic cancer	1.92e-05	6.51e-05	CcSEcCtD
Efavirenz—Dermatitis—Etoposide—hematologic cancer	1.92e-05	6.5e-05	CcSEcCtD
Efavirenz—Headache—Etoposide—hematologic cancer	1.91e-05	6.46e-05	CcSEcCtD
Efavirenz—Flatulence—Doxorubicin—hematologic cancer	1.91e-05	6.46e-05	CcSEcCtD
Efavirenz—Myalgia—Methotrexate—hematologic cancer	1.9e-05	6.45e-05	CcSEcCtD
Efavirenz—Arthralgia—Methotrexate—hematologic cancer	1.9e-05	6.45e-05	CcSEcCtD
Efavirenz—Chest pain—Methotrexate—hematologic cancer	1.9e-05	6.45e-05	CcSEcCtD
Efavirenz—Tension—Doxorubicin—hematologic cancer	1.9e-05	6.43e-05	CcSEcCtD
Efavirenz—Decreased appetite—Prednisone—hematologic cancer	1.9e-05	6.43e-05	CcSEcCtD
Efavirenz—Dysgeusia—Doxorubicin—hematologic cancer	1.89e-05	6.42e-05	CcSEcCtD
Efavirenz—Rash—Prednisolone—hematologic cancer	1.89e-05	6.42e-05	CcSEcCtD
Efavirenz—Dermatitis—Prednisolone—hematologic cancer	1.89e-05	6.41e-05	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	1.89e-05	6.4e-05	CcSEcCtD
Efavirenz—Malaise—Epirubicin—hematologic cancer	1.89e-05	6.39e-05	CcSEcCtD
Efavirenz—Fatigue—Prednisone—hematologic cancer	1.88e-05	6.38e-05	CcSEcCtD
Efavirenz—Headache—Prednisolone—hematologic cancer	1.88e-05	6.38e-05	CcSEcCtD
Efavirenz—Discomfort—Methotrexate—hematologic cancer	1.88e-05	6.37e-05	CcSEcCtD
Efavirenz—Nervousness—Doxorubicin—hematologic cancer	1.88e-05	6.37e-05	CcSEcCtD
Efavirenz—Vertigo—Epirubicin—hematologic cancer	1.88e-05	6.37e-05	CcSEcCtD
Efavirenz—Syncope—Epirubicin—hematologic cancer	1.88e-05	6.36e-05	CcSEcCtD
Efavirenz—Back pain—Doxorubicin—hematologic cancer	1.87e-05	6.34e-05	CcSEcCtD
Efavirenz—Constipation—Prednisone—hematologic cancer	1.87e-05	6.32e-05	CcSEcCtD
Efavirenz—Palpitations—Epirubicin—hematologic cancer	1.85e-05	6.26e-05	CcSEcCtD
Efavirenz—Confusional state—Methotrexate—hematologic cancer	1.84e-05	6.23e-05	CcSEcCtD
Efavirenz—Loss of consciousness—Epirubicin—hematologic cancer	1.84e-05	6.23e-05	CcSEcCtD
Efavirenz—Dizziness—Triamcinolone—hematologic cancer	1.83e-05	6.19e-05	CcSEcCtD
Efavirenz—Cough—Epirubicin—hematologic cancer	1.82e-05	6.18e-05	CcSEcCtD
Efavirenz—Vision blurred—Doxorubicin—hematologic cancer	1.82e-05	6.18e-05	CcSEcCtD
Efavirenz—Convulsion—Epirubicin—hematologic cancer	1.81e-05	6.14e-05	CcSEcCtD
Efavirenz—Nausea—Etoposide—hematologic cancer	1.81e-05	6.13e-05	CcSEcCtD
Efavirenz—Hypertension—Epirubicin—hematologic cancer	1.81e-05	6.12e-05	CcSEcCtD
Efavirenz—Feeling abnormal—Prednisone—hematologic cancer	1.8e-05	6.09e-05	CcSEcCtD
Efavirenz—Asthenia—Betamethasone—hematologic cancer	1.8e-05	6.09e-05	CcSEcCtD
Efavirenz—Asthenia—Dexamethasone—hematologic cancer	1.8e-05	6.09e-05	CcSEcCtD
Efavirenz—Ill-defined disorder—Doxorubicin—hematologic cancer	1.8e-05	6.08e-05	CcSEcCtD
Efavirenz—Nervous system disorder—Methotrexate—hematologic cancer	1.79e-05	6.06e-05	CcSEcCtD
Efavirenz—Anaemia—Doxorubicin—hematologic cancer	1.79e-05	6.06e-05	CcSEcCtD
Efavirenz—Thrombocytopenia—Methotrexate—hematologic cancer	1.79e-05	6.05e-05	CcSEcCtD
Efavirenz—Gastrointestinal pain—Prednisone—hematologic cancer	1.78e-05	6.05e-05	CcSEcCtD
Efavirenz—Nausea—Prednisolone—hematologic cancer	1.78e-05	6.04e-05	CcSEcCtD
Efavirenz—Chest pain—Epirubicin—hematologic cancer	1.78e-05	6.03e-05	CcSEcCtD
Efavirenz—Arthralgia—Epirubicin—hematologic cancer	1.78e-05	6.03e-05	CcSEcCtD
Efavirenz—Myalgia—Epirubicin—hematologic cancer	1.78e-05	6.03e-05	CcSEcCtD
Efavirenz—Agitation—Doxorubicin—hematologic cancer	1.78e-05	6.03e-05	CcSEcCtD
Efavirenz—Anxiety—Epirubicin—hematologic cancer	1.77e-05	6.01e-05	CcSEcCtD
Efavirenz—Pruritus—Dexamethasone—hematologic cancer	1.77e-05	6.01e-05	CcSEcCtD
Efavirenz—Pruritus—Betamethasone—hematologic cancer	1.77e-05	6.01e-05	CcSEcCtD
Efavirenz—Skin disorder—Methotrexate—hematologic cancer	1.77e-05	6e-05	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	1.77e-05	5.99e-05	CcSEcCtD
Efavirenz—Hyperhidrosis—Methotrexate—hematologic cancer	1.76e-05	5.97e-05	CcSEcCtD
Efavirenz—Discomfort—Epirubicin—hematologic cancer	1.76e-05	5.96e-05	CcSEcCtD
Efavirenz—Vomiting—Triamcinolone—hematologic cancer	1.76e-05	5.95e-05	CcSEcCtD
Efavirenz—Malaise—Doxorubicin—hematologic cancer	1.74e-05	5.91e-05	CcSEcCtD
Efavirenz—Rash—Triamcinolone—hematologic cancer	1.74e-05	5.9e-05	CcSEcCtD
Efavirenz—Dry mouth—Epirubicin—hematologic cancer	1.74e-05	5.9e-05	CcSEcCtD
Efavirenz—Dermatitis—Triamcinolone—hematologic cancer	1.74e-05	5.9e-05	CcSEcCtD
Efavirenz—Vertigo—Doxorubicin—hematologic cancer	1.74e-05	5.89e-05	CcSEcCtD
Efavirenz—Anorexia—Methotrexate—hematologic cancer	1.74e-05	5.89e-05	CcSEcCtD
Efavirenz—Syncope—Doxorubicin—hematologic cancer	1.74e-05	5.88e-05	CcSEcCtD
Efavirenz—Urticaria—Prednisone—hematologic cancer	1.73e-05	5.87e-05	CcSEcCtD
Efavirenz—Headache—Triamcinolone—hematologic cancer	1.73e-05	5.86e-05	CcSEcCtD
Efavirenz—Abdominal pain—Prednisone—hematologic cancer	1.72e-05	5.85e-05	CcSEcCtD
Efavirenz—Body temperature increased—Prednisone—hematologic cancer	1.72e-05	5.85e-05	CcSEcCtD
Efavirenz—Confusional state—Epirubicin—hematologic cancer	1.72e-05	5.83e-05	CcSEcCtD
Efavirenz—Diarrhoea—Dexamethasone—hematologic cancer	1.71e-05	5.81e-05	CcSEcCtD
Efavirenz—Diarrhoea—Betamethasone—hematologic cancer	1.71e-05	5.81e-05	CcSEcCtD
Efavirenz—Palpitations—Doxorubicin—hematologic cancer	1.71e-05	5.79e-05	CcSEcCtD
Efavirenz—Loss of consciousness—Doxorubicin—hematologic cancer	1.7e-05	5.76e-05	CcSEcCtD
Efavirenz—Cough—Doxorubicin—hematologic cancer	1.69e-05	5.72e-05	CcSEcCtD
Efavirenz—Shock—Epirubicin—hematologic cancer	1.68e-05	5.69e-05	CcSEcCtD
Efavirenz—Convulsion—Doxorubicin—hematologic cancer	1.68e-05	5.68e-05	CcSEcCtD
Efavirenz—Nervous system disorder—Epirubicin—hematologic cancer	1.67e-05	5.67e-05	CcSEcCtD
Efavirenz—Thrombocytopenia—Epirubicin—hematologic cancer	1.67e-05	5.66e-05	CcSEcCtD
Efavirenz—Hypertension—Doxorubicin—hematologic cancer	1.67e-05	5.66e-05	CcSEcCtD
Efavirenz—Tachycardia—Epirubicin—hematologic cancer	1.67e-05	5.64e-05	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.66e-05	5.63e-05	CcSEcCtD
Efavirenz—Skin disorder—Epirubicin—hematologic cancer	1.66e-05	5.62e-05	CcSEcCtD
Efavirenz—Dizziness—Betamethasone—hematologic cancer	1.66e-05	5.62e-05	CcSEcCtD
Efavirenz—Dizziness—Dexamethasone—hematologic cancer	1.66e-05	5.62e-05	CcSEcCtD
Efavirenz—Hyperhidrosis—Epirubicin—hematologic cancer	1.65e-05	5.59e-05	CcSEcCtD
Efavirenz—Insomnia—Methotrexate—hematologic cancer	1.65e-05	5.59e-05	CcSEcCtD
Efavirenz—Myalgia—Doxorubicin—hematologic cancer	1.65e-05	5.58e-05	CcSEcCtD
Efavirenz—Chest pain—Doxorubicin—hematologic cancer	1.65e-05	5.58e-05	CcSEcCtD
Efavirenz—Arthralgia—Doxorubicin—hematologic cancer	1.65e-05	5.58e-05	CcSEcCtD
Efavirenz—Anxiety—Doxorubicin—hematologic cancer	1.64e-05	5.56e-05	CcSEcCtD
Efavirenz—Nausea—Triamcinolone—hematologic cancer	1.64e-05	5.56e-05	CcSEcCtD
Efavirenz—Paraesthesia—Methotrexate—hematologic cancer	1.64e-05	5.55e-05	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	1.64e-05	5.54e-05	CcSEcCtD
Efavirenz—Discomfort—Doxorubicin—hematologic cancer	1.63e-05	5.52e-05	CcSEcCtD
Efavirenz—Anorexia—Epirubicin—hematologic cancer	1.63e-05	5.51e-05	CcSEcCtD
Efavirenz—Dyspnoea—Methotrexate—hematologic cancer	1.63e-05	5.51e-05	CcSEcCtD
Efavirenz—Somnolence—Methotrexate—hematologic cancer	1.62e-05	5.49e-05	CcSEcCtD
Efavirenz—Dry mouth—Doxorubicin—hematologic cancer	1.61e-05	5.46e-05	CcSEcCtD
Efavirenz—Hypersensitivity—Prednisone—hematologic cancer	1.61e-05	5.45e-05	CcSEcCtD
Efavirenz—Dyspepsia—Methotrexate—hematologic cancer	1.61e-05	5.44e-05	CcSEcCtD
Efavirenz—Vomiting—Dexamethasone—hematologic cancer	1.59e-05	5.4e-05	CcSEcCtD
Efavirenz—Vomiting—Betamethasone—hematologic cancer	1.59e-05	5.4e-05	CcSEcCtD
Efavirenz—Confusional state—Doxorubicin—hematologic cancer	1.59e-05	5.4e-05	CcSEcCtD
Efavirenz—Decreased appetite—Methotrexate—hematologic cancer	1.59e-05	5.37e-05	CcSEcCtD
Efavirenz—Rash—Betamethasone—hematologic cancer	1.58e-05	5.35e-05	CcSEcCtD
Efavirenz—Rash—Dexamethasone—hematologic cancer	1.58e-05	5.35e-05	CcSEcCtD
Efavirenz—Dermatitis—Betamethasone—hematologic cancer	1.58e-05	5.35e-05	CcSEcCtD
Efavirenz—Dermatitis—Dexamethasone—hematologic cancer	1.58e-05	5.35e-05	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Methotrexate—hematologic cancer	1.57e-05	5.34e-05	CcSEcCtD
Efavirenz—Fatigue—Methotrexate—hematologic cancer	1.57e-05	5.33e-05	CcSEcCtD
Efavirenz—Headache—Dexamethasone—hematologic cancer	1.57e-05	5.32e-05	CcSEcCtD
Efavirenz—Headache—Betamethasone—hematologic cancer	1.57e-05	5.32e-05	CcSEcCtD
Efavirenz—Asthenia—Prednisone—hematologic cancer	1.57e-05	5.31e-05	CcSEcCtD
Efavirenz—Pain—Methotrexate—hematologic cancer	1.56e-05	5.29e-05	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.55e-05	5.27e-05	CcSEcCtD
Efavirenz—Shock—Doxorubicin—hematologic cancer	1.55e-05	5.27e-05	CcSEcCtD
Efavirenz—Nervous system disorder—Doxorubicin—hematologic cancer	1.55e-05	5.25e-05	CcSEcCtD
Efavirenz—Thrombocytopenia—Doxorubicin—hematologic cancer	1.55e-05	5.24e-05	CcSEcCtD
Efavirenz—Pruritus—Prednisone—hematologic cancer	1.54e-05	5.23e-05	CcSEcCtD
Efavirenz—Insomnia—Epirubicin—hematologic cancer	1.54e-05	5.23e-05	CcSEcCtD
Efavirenz—Tachycardia—Doxorubicin—hematologic cancer	1.54e-05	5.22e-05	CcSEcCtD
Efavirenz—Skin disorder—Doxorubicin—hematologic cancer	1.53e-05	5.2e-05	CcSEcCtD
Efavirenz—Paraesthesia—Epirubicin—hematologic cancer	1.53e-05	5.19e-05	CcSEcCtD
Efavirenz—Hyperhidrosis—Doxorubicin—hematologic cancer	1.53e-05	5.17e-05	CcSEcCtD
Efavirenz—Dyspnoea—Epirubicin—hematologic cancer	1.52e-05	5.16e-05	CcSEcCtD
Efavirenz—Somnolence—Epirubicin—hematologic cancer	1.52e-05	5.14e-05	CcSEcCtD
Efavirenz—Anorexia—Doxorubicin—hematologic cancer	1.51e-05	5.1e-05	CcSEcCtD
Efavirenz—Feeling abnormal—Methotrexate—hematologic cancer	1.5e-05	5.09e-05	CcSEcCtD
Efavirenz—Dyspepsia—Epirubicin—hematologic cancer	1.5e-05	5.09e-05	CcSEcCtD
Efavirenz—Diarrhoea—Prednisone—hematologic cancer	1.49e-05	5.06e-05	CcSEcCtD
Efavirenz—Gastrointestinal pain—Methotrexate—hematologic cancer	1.49e-05	5.05e-05	CcSEcCtD
Efavirenz—Nausea—Betamethasone—hematologic cancer	1.49e-05	5.04e-05	CcSEcCtD
Efavirenz—Nausea—Dexamethasone—hematologic cancer	1.49e-05	5.04e-05	CcSEcCtD
Efavirenz—Decreased appetite—Epirubicin—hematologic cancer	1.48e-05	5.03e-05	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.47e-05	4.99e-05	CcSEcCtD
Efavirenz—Fatigue—Epirubicin—hematologic cancer	1.47e-05	4.99e-05	CcSEcCtD
Efavirenz—Constipation—Epirubicin—hematologic cancer	1.46e-05	4.95e-05	CcSEcCtD
Efavirenz—Pain—Epirubicin—hematologic cancer	1.46e-05	4.95e-05	CcSEcCtD
Efavirenz—Urticaria—Methotrexate—hematologic cancer	1.45e-05	4.91e-05	CcSEcCtD
Efavirenz—Dizziness—Prednisone—hematologic cancer	1.44e-05	4.89e-05	CcSEcCtD
Efavirenz—Body temperature increased—Methotrexate—hematologic cancer	1.44e-05	4.89e-05	CcSEcCtD
Efavirenz—Abdominal pain—Methotrexate—hematologic cancer	1.44e-05	4.89e-05	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.44e-05	4.88e-05	CcSEcCtD
Efavirenz—Insomnia—Doxorubicin—hematologic cancer	1.43e-05	4.84e-05	CcSEcCtD
Efavirenz—Paraesthesia—Doxorubicin—hematologic cancer	1.42e-05	4.81e-05	CcSEcCtD
Efavirenz—Dyspnoea—Doxorubicin—hematologic cancer	1.41e-05	4.77e-05	CcSEcCtD
Efavirenz—Feeling abnormal—Epirubicin—hematologic cancer	1.41e-05	4.77e-05	CcSEcCtD
Efavirenz—Somnolence—Doxorubicin—hematologic cancer	1.4e-05	4.76e-05	CcSEcCtD
Efavirenz—Gastrointestinal pain—Epirubicin—hematologic cancer	1.4e-05	4.73e-05	CcSEcCtD
Efavirenz—Dyspepsia—Doxorubicin—hematologic cancer	1.39e-05	4.71e-05	CcSEcCtD
Efavirenz—Vomiting—Prednisone—hematologic cancer	1.39e-05	4.7e-05	CcSEcCtD
Efavirenz—Rash—Prednisone—hematologic cancer	1.38e-05	4.66e-05	CcSEcCtD
Efavirenz—Dermatitis—Prednisone—hematologic cancer	1.37e-05	4.66e-05	CcSEcCtD
Efavirenz—Decreased appetite—Doxorubicin—hematologic cancer	1.37e-05	4.65e-05	CcSEcCtD
Efavirenz—Headache—Prednisone—hematologic cancer	1.37e-05	4.63e-05	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.36e-05	4.62e-05	CcSEcCtD
Efavirenz—Fatigue—Doxorubicin—hematologic cancer	1.36e-05	4.61e-05	CcSEcCtD
Efavirenz—Urticaria—Epirubicin—hematologic cancer	1.36e-05	4.59e-05	CcSEcCtD
Efavirenz—Constipation—Doxorubicin—hematologic cancer	1.35e-05	4.58e-05	CcSEcCtD
Efavirenz—Pain—Doxorubicin—hematologic cancer	1.35e-05	4.58e-05	CcSEcCtD
Efavirenz—Body temperature increased—Epirubicin—hematologic cancer	1.35e-05	4.57e-05	CcSEcCtD
Efavirenz—Abdominal pain—Epirubicin—hematologic cancer	1.35e-05	4.57e-05	CcSEcCtD
Efavirenz—Hypersensitivity—Methotrexate—hematologic cancer	1.34e-05	4.55e-05	CcSEcCtD
Efavirenz—Asthenia—Methotrexate—hematologic cancer	1.31e-05	4.43e-05	CcSEcCtD
Efavirenz—Feeling abnormal—Doxorubicin—hematologic cancer	1.3e-05	4.41e-05	CcSEcCtD
Efavirenz—Nausea—Prednisone—hematologic cancer	1.3e-05	4.39e-05	CcSEcCtD
Efavirenz—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.29e-05	4.38e-05	CcSEcCtD
Efavirenz—Pruritus—Methotrexate—hematologic cancer	1.29e-05	4.37e-05	CcSEcCtD
Efavirenz—Hypersensitivity—Epirubicin—hematologic cancer	1.26e-05	4.26e-05	CcSEcCtD
Efavirenz—Urticaria—Doxorubicin—hematologic cancer	1.25e-05	4.25e-05	CcSEcCtD
Efavirenz—Abdominal pain—Doxorubicin—hematologic cancer	1.25e-05	4.23e-05	CcSEcCtD
Efavirenz—Body temperature increased—Doxorubicin—hematologic cancer	1.25e-05	4.23e-05	CcSEcCtD
Efavirenz—Diarrhoea—Methotrexate—hematologic cancer	1.25e-05	4.23e-05	CcSEcCtD
Efavirenz—Asthenia—Epirubicin—hematologic cancer	1.22e-05	4.15e-05	CcSEcCtD
Efavirenz—Pruritus—Epirubicin—hematologic cancer	1.21e-05	4.09e-05	CcSEcCtD
Efavirenz—Dizziness—Methotrexate—hematologic cancer	1.21e-05	4.09e-05	CcSEcCtD
Efavirenz—Diarrhoea—Epirubicin—hematologic cancer	1.17e-05	3.96e-05	CcSEcCtD
Efavirenz—Hypersensitivity—Doxorubicin—hematologic cancer	1.16e-05	3.94e-05	CcSEcCtD
Efavirenz—Vomiting—Methotrexate—hematologic cancer	1.16e-05	3.93e-05	CcSEcCtD
Efavirenz—Rash—Methotrexate—hematologic cancer	1.15e-05	3.9e-05	CcSEcCtD
Efavirenz—Dermatitis—Methotrexate—hematologic cancer	1.15e-05	3.89e-05	CcSEcCtD
Efavirenz—Headache—Methotrexate—hematologic cancer	1.14e-05	3.87e-05	CcSEcCtD
Efavirenz—Asthenia—Doxorubicin—hematologic cancer	1.13e-05	3.84e-05	CcSEcCtD
Efavirenz—Dizziness—Epirubicin—hematologic cancer	1.13e-05	3.82e-05	CcSEcCtD
Efavirenz—Pruritus—Doxorubicin—hematologic cancer	1.12e-05	3.79e-05	CcSEcCtD
Efavirenz—Vomiting—Epirubicin—hematologic cancer	1.09e-05	3.68e-05	CcSEcCtD
Efavirenz—Nausea—Methotrexate—hematologic cancer	1.08e-05	3.67e-05	CcSEcCtD
Efavirenz—Diarrhoea—Doxorubicin—hematologic cancer	1.08e-05	3.66e-05	CcSEcCtD
Efavirenz—Rash—Epirubicin—hematologic cancer	1.08e-05	3.65e-05	CcSEcCtD
Efavirenz—Dermatitis—Epirubicin—hematologic cancer	1.08e-05	3.64e-05	CcSEcCtD
Efavirenz—Headache—Epirubicin—hematologic cancer	1.07e-05	3.62e-05	CcSEcCtD
Efavirenz—Dizziness—Doxorubicin—hematologic cancer	1.04e-05	3.54e-05	CcSEcCtD
Efavirenz—Nausea—Epirubicin—hematologic cancer	1.01e-05	3.44e-05	CcSEcCtD
Efavirenz—Vomiting—Doxorubicin—hematologic cancer	1e-05	3.4e-05	CcSEcCtD
Efavirenz—Rash—Doxorubicin—hematologic cancer	9.96e-06	3.37e-05	CcSEcCtD
Efavirenz—Dermatitis—Doxorubicin—hematologic cancer	9.95e-06	3.37e-05	CcSEcCtD
Efavirenz—Headache—Doxorubicin—hematologic cancer	9.89e-06	3.35e-05	CcSEcCtD
Efavirenz—Nausea—Doxorubicin—hematologic cancer	9.38e-06	3.18e-05	CcSEcCtD
Efavirenz—CYP2C9—Metabolism—CA9—hematologic cancer	5.78e-06	0.000297	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—SPHK1—hematologic cancer	5.77e-06	0.000296	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—NCOR2—hematologic cancer	5.75e-06	0.000296	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—NCOR2—hematologic cancer	5.7e-06	0.000293	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—AGRN—hematologic cancer	5.7e-06	0.000293	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PC—hematologic cancer	5.69e-06	0.000292	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—UGT1A1—hematologic cancer	5.54e-06	0.000285	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GBA—hematologic cancer	5.5e-06	0.000282	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—SLC35B2—hematologic cancer	5.5e-06	0.000282	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—IDH1—hematologic cancer	5.48e-06	0.000282	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—IDH1—hematologic cancer	5.43e-06	0.000279	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ABCC3—hematologic cancer	5.42e-06	0.000278	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—TXN—hematologic cancer	5.42e-06	0.000278	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—GSTO1—hematologic cancer	5.42e-06	0.000278	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—HMMR—hematologic cancer	5.4e-06	0.000277	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—IDH2—hematologic cancer	5.4e-06	0.000277	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CRABP1—hematologic cancer	5.39e-06	0.000277	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—SLC22A1—hematologic cancer	5.39e-06	0.000277	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ABCC3—hematologic cancer	5.37e-06	0.000276	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—TXN—hematologic cancer	5.37e-06	0.000276	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—GSTO1—hematologic cancer	5.37e-06	0.000276	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—SPHK1—hematologic cancer	5.3e-06	0.000272	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—SPHK1—hematologic cancer	5.26e-06	0.00027	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—ALOX5—hematologic cancer	5.25e-06	0.00027	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—UGT1A1—hematologic cancer	5.1e-06	0.000262	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	5.09e-06	0.000262	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—NUP98—hematologic cancer	5.09e-06	0.000261	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ARNTL—hematologic cancer	5.08e-06	0.000261	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—UGT1A1—hematologic cancer	5.05e-06	0.00026	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—MTAP—hematologic cancer	5.03e-06	0.000258	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—CD44—hematologic cancer	5.03e-06	0.000258	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—NQO1—hematologic cancer	5.03e-06	0.000258	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—SLC22A1—hematologic cancer	4.96e-06	0.000255	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CRABP1—hematologic cancer	4.96e-06	0.000255	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ACP5—hematologic cancer	4.94e-06	0.000254	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CA9—hematologic cancer	4.94e-06	0.000254	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—NCOA3—hematologic cancer	4.94e-06	0.000254	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—ADCY7—hematologic cancer	4.94e-06	0.000254	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—SLC22A1—hematologic cancer	4.91e-06	0.000252	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CRABP1—hematologic cancer	4.91e-06	0.000252	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—NUP214—hematologic cancer	4.9e-06	0.000252	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—NCOR2—hematologic cancer	4.88e-06	0.00025	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	4.85e-06	0.000249	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ALOX5—hematologic cancer	4.83e-06	0.000248	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—MTR—hematologic cancer	4.8e-06	0.000247	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—ABCG2—hematologic cancer	4.8e-06	0.000247	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ALOX5—hematologic cancer	4.79e-06	0.000246	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—CYCS—hematologic cancer	4.76e-06	0.000244	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—HSP90AA1—hematologic cancer	4.73e-06	0.000243	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—ENO2—hematologic cancer	4.71e-06	0.000242	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—NUP98—hematologic cancer	4.68e-06	0.00024	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—IDH1—hematologic cancer	4.64e-06	0.000239	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—NUP98—hematologic cancer	4.64e-06	0.000238	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—TXN—hematologic cancer	4.59e-06	0.000236	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ABCC3—hematologic cancer	4.59e-06	0.000236	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GSTO1—hematologic cancer	4.59e-06	0.000236	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—GSTT1—hematologic cancer	4.57e-06	0.000235	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ADCY7—hematologic cancer	4.54e-06	0.000233	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—NCOA3—hematologic cancer	4.54e-06	0.000233	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—NUP214—hematologic cancer	4.51e-06	0.000232	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ADCY7—hematologic cancer	4.5e-06	0.000231	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—NCOA3—hematologic cancer	4.5e-06	0.000231	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	4.5e-06	0.000231	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—SPHK1—hematologic cancer	4.49e-06	0.000231	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—FHL2—hematologic cancer	4.48e-06	0.00023	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—NUP214—hematologic cancer	4.47e-06	0.00023	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—SDC1—hematologic cancer	4.47e-06	0.000229	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	4.43e-06	0.000227	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—MTR—hematologic cancer	4.42e-06	0.000227	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ABCG2—hematologic cancer	4.42e-06	0.000227	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—AGRN—hematologic cancer	4.4e-06	0.000226	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—MTR—hematologic cancer	4.38e-06	0.000225	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ABCG2—hematologic cancer	4.38e-06	0.000225	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ENO2—hematologic cancer	4.33e-06	0.000223	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—UGT1A1—hematologic cancer	4.32e-06	0.000222	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ENO2—hematologic cancer	4.3e-06	0.000221	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.27e-06	0.000219	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	4.21e-06	0.000216	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—GSTT1—hematologic cancer	4.2e-06	0.000216	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—SLC22A1—hematologic cancer	4.2e-06	0.000216	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CRABP1—hematologic cancer	4.2e-06	0.000216	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—GSTP1—hematologic cancer	4.19e-06	0.000215	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—IDH2—hematologic cancer	4.17e-06	0.000214	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—HMMR—hematologic cancer	4.17e-06	0.000214	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—GSTT1—hematologic cancer	4.17e-06	0.000214	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—SDC1—hematologic cancer	4.11e-06	0.000211	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	4.1e-06	0.000211	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ALOX5—hematologic cancer	4.09e-06	0.00021	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—SDC1—hematologic cancer	4.07e-06	0.000209	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	4.03e-06	0.000207	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—ABCB1—hematologic cancer	3.97e-06	0.000204	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—NUP98—hematologic cancer	3.96e-06	0.000204	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ARNTL—hematologic cancer	3.92e-06	0.000201	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.89e-06	0.0002	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—NCOR1—hematologic cancer	3.85e-06	0.000198	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—GSTM1—hematologic cancer	3.85e-06	0.000198	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ADCY7—hematologic cancer	3.85e-06	0.000198	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—NCOA3—hematologic cancer	3.85e-06	0.000198	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.84e-06	0.000197	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—NUP214—hematologic cancer	3.82e-06	0.000196	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CA9—hematologic cancer	3.81e-06	0.000196	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ACP5—hematologic cancer	3.81e-06	0.000196	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CD44—hematologic cancer	3.8e-06	0.000195	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—NQO1—hematologic cancer	3.8e-06	0.000195	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	3.78e-06	0.000194	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—NCOR2—hematologic cancer	3.76e-06	0.000193	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—MTR—hematologic cancer	3.74e-06	0.000192	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ABCG2—hematologic cancer	3.74e-06	0.000192	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.72e-06	0.000191	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.67e-06	0.000189	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ENO2—hematologic cancer	3.67e-06	0.000189	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CYCS—hematologic cancer	3.59e-06	0.000185	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—IDH1—hematologic cancer	3.58e-06	0.000184	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	3.57e-06	0.000183	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GSTT1—hematologic cancer	3.56e-06	0.000183	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ABCC3—hematologic cancer	3.54e-06	0.000182	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—TXN—hematologic cancer	3.54e-06	0.000182	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GSTO1—hematologic cancer	3.54e-06	0.000182	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	3.51e-06	0.00018	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—NQO1—hematologic cancer	3.49e-06	0.000179	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CD44—hematologic cancer	3.49e-06	0.000179	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—SDC1—hematologic cancer	3.48e-06	0.000179	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—SPHK1—hematologic cancer	3.47e-06	0.000178	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—NQO1—hematologic cancer	3.46e-06	0.000178	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CD44—hematologic cancer	3.46e-06	0.000178	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—MTHFR—hematologic cancer	3.4e-06	0.000175	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.39e-06	0.000174	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—UGT1A1—hematologic cancer	3.33e-06	0.000171	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.32e-06	0.000171	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CYCS—hematologic cancer	3.31e-06	0.00017	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	3.28e-06	0.000169	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.28e-06	0.000169	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CYCS—hematologic cancer	3.28e-06	0.000168	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	3.26e-06	0.000167	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CRABP1—hematologic cancer	3.24e-06	0.000166	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—SLC22A1—hematologic cancer	3.24e-06	0.000166	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.21e-06	0.000165	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—GSTP1—hematologic cancer	3.17e-06	0.000163	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ALOX5—hematologic cancer	3.16e-06	0.000162	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.14e-06	0.000161	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.06e-06	0.000157	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—NUP98—hematologic cancer	3.06e-06	0.000157	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—ABCB1—hematologic cancer	3e-06	0.000154	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ADCY7—hematologic cancer	2.97e-06	0.000153	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—NCOA3—hematologic cancer	2.97e-06	0.000153	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—NQO1—hematologic cancer	2.96e-06	0.000152	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CD44—hematologic cancer	2.96e-06	0.000152	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—NUP214—hematologic cancer	2.95e-06	0.000151	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.93e-06	0.00015	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—GSTP1—hematologic cancer	2.91e-06	0.00015	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—GSTM1—hematologic cancer	2.91e-06	0.00015	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—NCOR1—hematologic cancer	2.91e-06	0.00015	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.9e-06	0.000149	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ABCG2—hematologic cancer	2.89e-06	0.000148	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—MTR—hematologic cancer	2.89e-06	0.000148	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—GSTP1—hematologic cancer	2.89e-06	0.000148	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PIK3CG—hematologic cancer	2.86e-06	0.000147	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ENO2—hematologic cancer	2.83e-06	0.000146	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CYCS—hematologic cancer	2.8e-06	0.000144	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.79e-06	0.000144	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	2.78e-06	0.000143	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ABCB1—hematologic cancer	2.76e-06	0.000142	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GSTT1—hematologic cancer	2.75e-06	0.000141	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ABCB1—hematologic cancer	2.73e-06	0.00014	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—SDC1—hematologic cancer	2.69e-06	0.000138	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—NCOR1—hematologic cancer	2.68e-06	0.000138	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—GSTM1—hematologic cancer	2.68e-06	0.000138	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—NCOR1—hematologic cancer	2.65e-06	0.000136	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—GSTM1—hematologic cancer	2.65e-06	0.000136	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—CREBBP—hematologic cancer	2.65e-06	0.000136	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—MTHFR—hematologic cancer	2.57e-06	0.000132	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PIK3CD—hematologic cancer	2.51e-06	0.000129	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.5e-06	0.000129	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—ALB—hematologic cancer	2.48e-06	0.000127	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GSTP1—hematologic cancer	2.47e-06	0.000127	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.39e-06	0.000123	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PIK3R1—hematologic cancer	2.37e-06	0.000122	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—MTHFR—hematologic cancer	2.37e-06	0.000122	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—MTHFR—hematologic cancer	2.35e-06	0.00012	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ABCB1—hematologic cancer	2.34e-06	0.00012	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—NQO1—hematologic cancer	2.28e-06	0.000117	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CD44—hematologic cancer	2.28e-06	0.000117	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—NCOR1—hematologic cancer	2.27e-06	0.000116	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GSTM1—hematologic cancer	2.27e-06	0.000116	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.27e-06	0.000116	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PIK3CB—hematologic cancer	2.19e-06	0.000113	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PIK3CG—hematologic cancer	2.16e-06	0.000111	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CYCS—hematologic cancer	2.16e-06	0.000111	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	2.15e-06	0.00011	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.07e-06	0.000106	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—MTHFR—hematologic cancer	2e-06	0.000103	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CREBBP—hematologic cancer	2e-06	0.000103	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PIK3CG—hematologic cancer	1.99e-06	0.000102	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PIK3CG—hematologic cancer	1.97e-06	0.000101	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GSTP1—hematologic cancer	1.9e-06	9.78e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PIK3CD—hematologic cancer	1.9e-06	9.76e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PTEN—hematologic cancer	1.89e-06	9.73e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—ALB—hematologic cancer	1.88e-06	9.63e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CREBBP—hematologic cancer	1.84e-06	9.47e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CREBBP—hematologic cancer	1.83e-06	9.39e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—EP300—hematologic cancer	1.81e-06	9.28e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.8e-06	9.26e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PIK3R1—hematologic cancer	1.79e-06	9.22e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.77e-06	9.07e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.75e-06	8.99e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.75e-06	8.99e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PIK3CD—hematologic cancer	1.75e-06	8.98e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PIK3CD—hematologic cancer	1.73e-06	8.9e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ALB—hematologic cancer	1.73e-06	8.86e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ALB—hematologic cancer	1.71e-06	8.78e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PIK3CG—hematologic cancer	1.68e-06	8.65e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PIK3CB—hematologic cancer	1.66e-06	8.51e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PIK3R1—hematologic cancer	1.65e-06	8.48e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PIK3R1—hematologic cancer	1.64e-06	8.4e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CREBBP—hematologic cancer	1.56e-06	8.02e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.55e-06	7.95e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PIK3CB—hematologic cancer	1.52e-06	7.82e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PIK3CB—hematologic cancer	1.51e-06	7.76e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PIK3CD—hematologic cancer	1.48e-06	7.6e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ALB—hematologic cancer	1.46e-06	7.51e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PTEN—hematologic cancer	1.43e-06	7.35e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PIK3R1—hematologic cancer	1.4e-06	7.18e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—EP300—hematologic cancer	1.36e-06	7.01e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PIK3CA—hematologic cancer	1.34e-06	6.86e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PTEN—hematologic cancer	1.32e-06	6.76e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PTEN—hematologic cancer	1.3e-06	6.7e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.3e-06	6.68e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PIK3CB—hematologic cancer	1.29e-06	6.63e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—EP300—hematologic cancer	1.26e-06	6.45e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—EP300—hematologic cancer	1.24e-06	6.39e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.21e-06	6.19e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.14e-06	5.87e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ALB—hematologic cancer	1.13e-06	5.79e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PTEN—hematologic cancer	1.12e-06	5.73e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—AKT1—hematologic cancer	1.09e-06	5.61e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.08e-06	5.54e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—EP300—hematologic cancer	1.06e-06	5.46e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PIK3CA—hematologic cancer	1.01e-06	5.19e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PIK3CB—hematologic cancer	9.96e-07	5.12e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PIK3CA—hematologic cancer	9.29e-07	4.77e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PIK3CA—hematologic cancer	9.21e-07	4.73e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PTEN—hematologic cancer	8.61e-07	4.42e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—AKT1—hematologic cancer	8.25e-07	4.24e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—EP300—hematologic cancer	8.21e-07	4.22e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PIK3CA—hematologic cancer	7.87e-07	4.04e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—AKT1—hematologic cancer	7.59e-07	3.9e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—AKT1—hematologic cancer	7.52e-07	3.86e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—AKT1—hematologic cancer	6.43e-07	3.3e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PIK3CA—hematologic cancer	6.07e-07	3.12e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—AKT1—hematologic cancer	4.96e-07	2.55e-05	CbGpPWpGaD
